Search for: "Sanofi Aventis US LLC "
Results 41 - 60
of 84
Sort by Relevance
|
Sort by Date
8 Apr 2012, 12:54 pm
Sanofi-Aventis U.S. [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
5 Feb 2012, 8:04 am
See Sanofi-Aventis chemist admits trade secret theft. [read post]
23 Jan 2012, 4:56 pm
Sanofi Aventis is a global healthcare company, headquartered in Bridgewater, New Jersey. [read post]
2 Dec 2011, 2:00 pm
Sanofi-Aventis United States LLC, 2011 WL 3666595, at *3 (W.D. [read post]
15 Sep 2011, 5:00 am
Sanofi-Aventis U.S. [read post]
16 Aug 2011, 11:35 pm
General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges… [read post]
10 Jul 2011, 11:29 pm
., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
29 Jun 2011, 3:34 am
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
20 May 2011, 8:53 am
Sanofi-Aventis U.S. [read post]
15 May 2011, 2:54 pm
Karst – Last week, the Federal Trade Commission (“FTC”) announced that the Commission’s Bureau of Competition (“Bureau”) sent letters (here, here, and here) to Sanofi-Aventis U.S. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis U.S. [read post]
9 Jan 2011, 9:09 pm
USA 1:11-cv-00018; filed January 6, 2011 in the District Court of Delaware • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
6 Oct 2010, 4:22 am
Highlights this week included: Prezista (Darunavir) – US NIH becomes first patent holder to join UNITAID Medicines Patent Pool (IP Watch) (KEI) Taxotere (Docetaxel) – US: District Court finds Sanofi’s Taxotere invalid: Aventis v Hospira (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think… [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
25 Aug 2010, 12:37 am
USPTO – Briefing schedule update (Patent Docs) US: Patent expiration, pediatric exclusivity, and generic drug approval – Some interesting tensions between the FDC Act and patent law (FDA Law Blog) Products Androderm (Testosterone) – US: False marking complaint based on Watson’s marking of its Androderm products: Promote Innovation LLC v. [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) US: District Court M D North Carolina: $4.8 million attorneys’ fee award designed to reimburse not punish: Aventis CropScience v. [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs) Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
21 May 2010, 2:32 am
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
5 May 2010, 4:46 am
(Patent Docs) Plavix (Clopidogrel) – Netherlands: District Court of The Hague finds Sanofi-Aventis’ patent invalid for lack of inventive step in proceedings brought by RatioPharm (EPLAW) Rapamune (Sirolimus) – US: Patent infringement complaint following Paragraph IV certification: Pfizer Inc. et al. v. [read post]
